Comparing recurrent antibiotic prescriptions in children treated with a brand name or a generic formulation

E-ISSN： 1099-1557|24|2|121-128

ISSN： 1053-8569

Source： PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, Vol.24, Iss.2, 2015-02, pp. : 121-128

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Brand name to generic substitution of antiepileptic drugs does not lead to seizure‐related hospitalization: a population‐based case‐crossover study

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, Vol. 24, Iss. 11, 2015-11 ,pp. : 1161-1169

John Wiley & Sons Inc

Access to resources Recommend Favorite

Generic lamotrigine versus brand‐name Lamictal bioequivalence in patients with epilepsy: A field test of the FDA bioequivalence standard

EPILEPSIA, Vol. 56, Iss. 9, 2015-09 ,pp. : 1415-1424

John Wiley & Sons Inc

Access to resources Recommend Favorite

Generic substitution in contravention of doctor's prescriptions

INTERNAL MEDICINE JOURNAL, Vol. 45, Iss. 10, 2015-10 ,pp. : 1093-1093

John Wiley & Sons Inc

Access to resources Recommend Favorite

Recurrent Subependymoma Treated with Radiosurgery

Stereotactic and Functional Neurosurgery, Vol. 82, Iss. 1, 2004-03 ,pp. : 58-60

Karger

Access to resources Recommend Favorite

Bevacizumab (BVZ)‐associated toxicities in children with recurrent central nervous system tumors treated with BVZ and irinotecan (CPT‐11)

CANCER, Vol. 119, Iss. 23, 2013-12 ,pp. : 4180-4187

John Wiley & Sons Inc

Access to resources Recommend Favorite